News & Updates
Filter by Specialty:

Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world
15 Aug 2024
byJairia Dela Cruz
Up to 3 months of treatment with adjunctive brexpiprazole helps with symptom severity in Asian adults with major depressive disorder (MDD) and inadequate response to antidepressants in a real-life clinical setting in Singapore.
Adjunctive brexpiprazole benefits seen in Asian adults with MDD in real-world
15 Aug 2024
Sildenafil shows promise as treatment for Alzheimer’s disease
15 Aug 2024
byStephen Padilla
Sildenafil, a phosphodiesterase type 5 inhibitor, can be a potential treatment for Alzheimer’s disease (AD), as shown in real-world data, AD patient-induced pluripotent stem cells (iPSC)-derived neuron models, and in vivo transgenic mouse model observations, according to a study presented at AAIC 2024.
Sildenafil shows promise as treatment for Alzheimer’s disease
15 Aug 2024
Processed red meat intake ups dementia risk
15 Aug 2024
byAudrey Abella
In a study that tracked over 100,000 individuals for over 40 years, the risk of dementia is higher among those who consumed about two servings of processed red meat per week as opposed to those who consumed less.